Oligonucleotide inhibitors of DNA methyltransferase for cancer therapeutics.

被引：0
|
作者：
Sufrin, JR
Brank, A
Marasco, C
Christman, JK
机构：
[1] Univ Nebraska, Med Ctr, Omaha, NE 68198 USA
[2] New York State Dept Hlth, Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
CLINICAL CANCER RESEARCH | 1999年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
295
引用
收藏
页码：3788S / 3788S
页数：1
相关论文
共 50 条
  • [1] Molecular Mechanisms of DNA Damage Associated with Oligonucleotide (OND) Therapeutics.
    Saleh, A.
    Gooderham, N.
    Priestley, C.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2014, 55 : S24 - S24
  • [2] Inhibitors of STAT dimerization as novel cancer therapeutics.
    Turkson, J
    Hamilton, A
    Sebti, S
    Jove, R
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3779S - 3780S
  • [3] Protein Methyltransferase Inhibitors as Cancer Therapeutics
    Copeland, Robert
    FASEB JOURNAL, 2015, 29
  • [4] Design of oligonucleotide inhibitors for human DNA methyltransferase 1
    Evdokimov, A. A.
    Zinoviev, V. V.
    Kuznetsov, V. V.
    Netesova, N. A.
    Malygin, E. G.
    MOLECULAR BIOLOGY, 2009, 43 (03) : 418 - 425
  • [5] Development of novel hsp90 inhibitors as cancer therapeutics.
    Chiosis, G
    Rosen, N
    Lucas, B
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U46 - U46
  • [6] Design of oligonucleotide inhibitors for human DNA methyltransferase 1
    A. A. Evdokimov
    V. V. Zinoviev
    V. V. Kuznetsov
    N. A. Netesova
    E. G. Malygin
    Molecular Biology, 2009, 43 : 418 - 425
  • [7] An Overview of the Nonclinical Development of Oligonucleotide-Based Therapeutics.
    Younis, H. S.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2014, 55 : S24 - S24
  • [8] Protein methyltransferase inhibitors as personalized cancer therapeutics
    Copeland, Robert A.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [9] Protein Methyltransferase Inhibitors as Personalized Cancer Therapeutics
    Copeland, Robert A.
    ONCOLOGIST, 2013, 18 : S2 - S2
  • [10] Protein methyltransferase inhibitors as personalized cancer therapeutics
    Copeland, Robert
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
12345